Associate Professor of Surgery and Oncology, University Tex Houston
General Surgery
Dr. Gildy V. Babiera, MD
|
|
Give Review
Gildy Babiera practices General Surgery. She attended NYU School of Medicine. She has 4 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". Doctor Gildy V. Babiera, MD is a published doctor and has 90 publications published. The lastest was: 'Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the Nation...
- Variation in metastatic workup for patients with invasive breast Cancer.
- Proton partial Breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.
- Molecular cytogenetic characterization of mammary neuroendocrine Carcinoma.
- Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer ...
- Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer.
- Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation.
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast Cancer.
- Shortened Radiation Therapy Schedules for Early-Stage Breast Cancer: A Review of Hypofractionated Whole-Breast Irradiation and Accelerated Partial Breast Irradiation.
- Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.
- Incidence and consequence of close margins in patients with ductal Carcinoma-in situ treated with mastectomy: is further therapy warranted?
- Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy.
- Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients.
- A focused curriculum in surgical oncology for the third-year medical students.
- Impact of chemotherapy sequencing on local-regional failure risk in breast Cancer patients undergoing breast-conserving therapy.
- Radiation dose escalation for loco-regional recurrence of breast Cancer after mastectomy.
- Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival.
- Biology, treatment, and outcome in very young and older women with DCIS.
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns.
- The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast Cancer.
- Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast Cancer patients with a positive sentinel l...
- Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers.
- Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer.
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy.
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Canc...
- Management of local-regional recurrence following immediate breast reconstruction in patients with early breast Cancer treated without postmastectomy radiotherapy.
- Delays in Primary Surgical Treatment Are Not Associated with Significant Tumor Size Progression in Breast Cancer Patients.
- Local, Regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- Sentinel lymph node dissection is technically feasible in older breast Cancer patients.
- Present-day locoregional control in patients with t1 or t2 breast Cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
- Does blue dye contribute to success of sentinel node mapping for breast Cancer?
- Factors affecting the decision of breast Cancer patients to undergo contralateral prophylactic mastectomy.
- Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast Cancer bef...
- Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive Breast...
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast Cancer patients.
- Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast Cancer.
- False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast Cancers may be higher in cases with large additive tumor burden.
- Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast Cancer patients.
- Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of Breast conservation.
- A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lym...
- Predictors of contralateral breast Cancer in patients with unilateral breast Cancer undergoing contralateral prophylactic mastectomy.
- Ductal Carcinoma in situ: state of the science and roadmap to advance the field.
- Metastatic breast Cancer: a paradigm shift toward a more aggressive approach.
- Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast Cancer pa...
- How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast Cancer?
- Timing of surgical intervention for the intact primary in stage IV breast Cancer patients.
- Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
- Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after Lumpectomy.
- Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the Breast.
- Low locoregional failure rates in selected breast Cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
- Role for intraoperative margin assessment in patients undergoing Breast-conserving surgery.
- Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast Cancer patients with documented axillary metastases.
- Locoregional Resection in Stage IV breast Cancer: tumor biology, molecular and clinical perspectives.
- Selective use of sentinel lymph node surgery during prophylactic mastectomy.
- Breast Cancer in the very elderly: treatment patterns and complications in a tertiary Cancer center.
- Comparative analysis of sentinel lymph node operation in male and female breast Cancer patients.
- The safety of Breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
- Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for Breast c...
- Sentinel lymph node surgery in locally recurrent breast Cancer.
- Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast Cancer.
- Effect of primary tumor extirpation in breast Cancer patients who present with stage IV disease and an intact primary tumor.
- The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the Breast.
- Validation of a breast Cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
- Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
- Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral Breast carcinoma recurrence and contralateral Breast carcinoma development in patients ...
- Determinants of mastectomy in Breast conservation therapy candidates.
- Predictors of systemic recurrence and disease-specific survival after ipsilateral Breast tumor recurrence.
- Improving local control with Breast-conserving therapy: a 27-year single-institution experience.
- Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in Breast carcinoma.
- Predictors of invasive breast Cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in manag...
- Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast Cancer patients und...
- Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
- The effect of ethnicity on immediate reconstruction rates after mastectomy for breast Cancer.
- Intramammary lymph node metastases are an independent predictor of poor outcome in patients with Breast carcinoma.
- Effective local control and long-term survival in patients with T4 locally advanced breast Cancer treated with breast conservation therapy.
- Feasibility of Breast-conserving surgery for patients with Breast carcinoma associated with nipple discharge.
- Small (< or = 2-cm) breast Cancer treated with US-guided radiofrequency ablation: feasibility study.
- Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal Carcinoma in situ.
- Potential applicability of balloon catheter-based accelerated partial Breast irradiation after conservative surgery for Breast carcinoma.
- Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with Breast-conserving surgery.
- Chest wall recurrence after mastectomy does not always portend a dismal outcome.
- Surgical decision making and factors determining a diagnosis of Breast carcinoma in women presenting with nipple discharge.
- Positive surgical margins and ipsilateral Breast tumor recurrence predict disease-specific survival after Breast-conserving therapy.
- High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast Cancer.
- Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast Cancer patients treated with neoadjuvant chemotherapy and post-mastectomy...
- Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
Schools
New York Med Coll
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Lymph Node Biopsy or Excision
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Biliary Atresia
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
NYU School of Medicine -
New York Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center -
Memorial Hermann Memorial City Medical Center
Drug Facts
| NPI NUMBER | 1821189754 | |
| NPPES Provider LastName | BABIERA | |
| NPPES Provider FirstName | GILDY | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 19.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821189754 |
| Last Name Of The Provider | BABIERA |
| First Name Of The Provider | GILDY |
| View All |
Similar Doctors
|
|
Dr. Reggie A. Vaden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith F. Fournier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariano A. Caceres, MD |
|
|
Dr. Wasim A. Dar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shabirhusain S. Abadin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee M. Ellis, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jose A. Moreno, MD |
|
|
Dr. James F. Martin, MD |
|
|
Dr. Michael J. Moustoukas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brian K. Lassinger, PA
This Doctor is OpenDoctor Recommended.
|